Based in Salt Lake City, Utah, Lineagen's mission is to accelerate and enhance the diagnostic evaluation of medical conditions so that the best possible outcomes can be achieved for patients and their families. Our first commercial offering, FirstStepDx PLUS, provide physicians with a fully integrated genetic testing, counseling, and developmental screening service to aid in the diagnostic evaluation of individuals with ASD or other forms of developmental delay. In addition to our deep commitment to ASD and developmental delay, we have ongoing scientific programs in the areas of multiple sclerosis (MS) and chronic obstructive pulmonary disease (COPD).
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 12/18/13 | $3,500,000 | Series C |
Hatteras Funds Kickstart Seed Fund Mesa Verde Venture Partners PrairieGold Venture Partners Sanderling Ventures Signal Peak Ventures University Venture Fund | undisclosed |
| 02/18/15 | $12,170,000 | Series C |
HealthQuest Capital Kickstart Seed Fund Mesa Verde Venture Partners Mountain Group Capital Petra Capital Partners PrairieGold Venture Partners Sanderling Ventures Signal Peak Ventures University Venture Fund | undisclosed |
